Vaginal and Oral Microbiome Crosstalk
Launched by TURKU UNIVERSITY HOSPITAL · Sep 7, 2016
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Vaginal and Oral Microbiome Crosstalk," is looking into the relationship between the bacteria found in the vagina and the mouth. Researchers will collect swab samples from participants to better understand how these two microbiomes interact. In some cases, a Pap smear, which is a test used to screen for cervical cancer, will also be performed.
The trial is currently recruiting women aged 65 to 74 who are visiting specific departments at Turku University Hospital or family planning clinics in Southwest Finland. If you meet these criteria and are interested in participating, you can expect to provide swab samples and possibly have a Pap smear. This research aims to provide valuable insights that could help improve women's health in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • patients coming to Turku University Hospital Dermato-Venereology or Gynaecology Departments or to family planning clinics in The wellbeing services county of Southwest Finland for previously mentioned reasons
- Exclusion Criteria:
- • those not meeting the criteria
About Turku University Hospital
Turku University Hospital (TYKS) is a leading academic medical center located in Turku, Finland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a key institution within the University of Turku, TYKS integrates cutting-edge medical education with state-of-the-art clinical services, offering a broad spectrum of specialized care. The hospital actively participates in clinical trials, facilitating the translation of scientific discoveries into practical treatments, and enhancing patient outcomes. With a multidisciplinary approach and a focus on collaboration, TYKS aims to contribute significantly to the global medical community through its rigorous research initiatives and commitment to patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Turku, , Finland
Patients applied
Trial Officials
Niina K Hieta, MD, PhD
Principal Investigator
specialist
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials